Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
27.1M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
21.8M
-
Shares change
-
-90.9K
-
Total reported value, excl. options
-
$322M
-
Value change
-
-$1.95M
-
Put/Call ratio
-
0.53
-
Number of buys
-
45
-
Number of sells
-
-62
-
Price
-
$14.82
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q3 2022
138 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock as of Q3 2022.
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.8M shares
of 27.1M outstanding shares and own 80.29% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (3.57M shares), STATE STREET CORP (2.73M shares), ARK Investment Management LLC (2.18M shares), BlackRock Inc. (1.96M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.46M shares), Nikko Asset Management Americas, Inc. (1.46M shares), VANGUARD GROUP INC (1.34M shares), FMR LLC (954K shares), Woodline Partners LP (878K shares), and Point72 Asset Management, L.P. (617K shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.